Literature DB >> 2644165

Bile duct injury as a part of diagnostic criteria for liver allograft rejection.

J Kemnitz1, B Ringe, T R Cohnert, G Gubernatis, H Choritz, A Georgii.   

Abstract

The decisive criterium of acute liver allograft rejection was found to be the presence of the diagnostic triad of acute rejection; ie, the presence of portal inflammatory mixed infiltrates, venous endothelialitis (both portal and central), and bile duct injury. On the basis of the presence of each of the components of the diagnostic triad, criteria for the diagnosis of different degrees of acute rejection were developed, particularly focusing attention on a detailed analysis of bile duct injury. Bile duct injury was shown to be an essential part of the histopathologic changes in all grades of acute rejection in the liver allograft, the grade of severity of bile duct injury correlating to a certain extent with the grade of severity of acute rejection. Our analyses have made it evident that bile duct injury, which most probably occurs earlier in the process of acute rejection than endothelialitis, is a more sensitive parameter than endothelialitis in the diagnosis of acute rejection. Furthermore, our analyses have revealed that bile duct injury in acute rejection is likely to be an irreversible process, depending on the number of episodes of acute rejection that previously occurred. On the other hand, it has become clear from our results that bile duct injury must not be considered to be an absolute histopathologic marker of acute rejection; however, it does have to be judged synoptically in connection with the other components of the diagnostic triad and the changes that the triad cause in the hepatic parenchyma. Additional analyses of the grade of severity of cholostases have shown that the cholostases are, to a certain degree, an accompanying phenomenon of the histopathologic changes characterizing acute rejection rather than a histopathologic change that is as significant as the presence of the components of the diagnostic triad.

Entities:  

Mesh:

Year:  1989        PMID: 2644165     DOI: 10.1016/0046-8177(89)90177-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Infusion of nonmyeloablative bone marrow alleviates acute rejection reaction in liver allotransplantation.

Authors:  Hai-yang Xie; Dong-sheng Huang; Chang-ku Jia; Shu-sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

2.  Immunotolerance of liver allotransplantation induced by intrathymic inoculation of donor soluble liver specific antigen.

Authors:  Chang-Ku Jia; Shu-Sen Zheng; Qi-Yong Li; Ai-Bin Zhang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.

Authors:  A Jain; A J Demetris; R Kashyap; K Blakomer; K Ruppert; A Khan; S Rohal; T E Starzl; J J Fung
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

4.  Adenovirus mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation.

Authors:  Guo-Ping Jiang; Zhen-Hua Hu; Shu-Sen Zheng; Chang-Ku Jia; Ai-Bin Zhang; Wei-Lin Wang
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

5.  Liver disease in rhesus monkeys infected with simian immunodeficiency virus.

Authors:  M A Gerber; M L Chen; F S Hu; G B Baskin; L Petrovich
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

6.  Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.

Authors:  O Pappo; H Ramos; T E Starzl; J J Fung; A J Demetris
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.